What Is Infectious Disease?

Q1 — Sample Band 6 response (8 marks), annotated

An infectious disease is a disease caused by a pathogen — an organism or agent that enters a host and causes harm — and that can be transmitted between hosts. BSE qualifies as an infectious disease because it meets both criteria: a defined causative agent (the misfolded prion protein) invades the bovine host and causes progressive neurological harm, and transmission occurs when cattle or humans ingest infected tissue. The fact that the agent is not a living cell does not disqualify it from being a pathogen or the disease from being infectious. [1 — defines infectious disease; justifies BSE as infectious despite unconventional cause]

The prion falls into the non-cellular pathogen category. A prion is a misfolded protein — it contains no nucleic acid (no DNA or RNA), no cell membrane, no cytoplasm, and no ribosomes. This fundamentally distinguishes it from bacteria (living prokaryotic cells with cell walls, DNA, and ribosomes, targeted by antibiotics), viruses (non-cellular but containing nucleic acid in a protein coat, targeted by antivirals), and fungi (living eukaryotic cells with ergosterol-containing membranes, targeted by antifungal agents). Because the prion has no cellular machinery and no nucleic acid, none of the drug categories that target living cells or replicating genomes has any effect on it. [1 — correct category; 1 — structural contrast with bacteria, viruses, and fungi including treatment implications]

Prions make disease control far more difficult than bacterial or viral diseases for at least two reasons. First, resistance to standard sterilisation: conventional autoclaving and chemical disinfectants that destroy bacteria and viruses are ineffective against prions, because prions are proteins — they do not have heat-sensitive enzymes or lipid membranes to disrupt. Contaminated equipment and farm soil can remain infectious for decades. Second, absence of nucleic acid: all existing antiviral and antibiotic strategies work by disrupting nucleic-acid replication or translation. Since prions contain no nucleic acid, there is no target for these drugs. No effective cure or drug treatment currently exists for BSE or vCJD. [1 — two specific prion properties; 1 — links each property to difficulty of control]

The two data collection methods served different but complementary purposes. Historical slaughterhouse records (secondary data): Strength — covered the entire UK cattle population across years, allowing epidemiologists to reconstruct the epidemic curve and identify when and where infected cattle entered the food chain. Limitation — record-keeping varied between abattoirs, and data were collected for commercial not epidemiological purposes, so completeness and accuracy could not be guaranteed. Post-mortem brain pathology (primary data): Strength — provided definitive confirmation of prion disease at the individual level; tissue microscopy revealed characteristic spongiform changes that could not be inferred from records alone. Limitation — required the animal or person to have already died; provided no information about the living population still in the incubation period. [1 — secondary data evaluation with strength and limitation; 1 — primary data evaluation with strength and limitation]

Judgement: BSE fits the standard definition of infectious disease (pathogen + transmissibility) but challenges the standard biological assumptions associated with it. The lesson's model assumes that pathogens are either living cells or viruses with nucleic acid — entities that can be targeted by known agents. Prion disease forces a third category: an agent that is neither living nor nucleic-acid-based, yet still transmissible and lethal. The lesson's framework is useful for classification but must be extended to account for the unique properties of prions when designing control strategies. [1 — evidence-based judgement that both affirms and qualifies the fit]

Marking criteria:

• 1 mark — Defines infectious disease (pathogen + transmissibility) and correctly justifies why BSE qualifies despite a non-living cause.
• 1 mark — Correctly classifies prion as non-cellular and identifies two structural features distinguishing it from other pathogen categories.
• 1 mark — Compares treatment implications across at least two other categories (antibiotics for bacteria; antivirals for viruses; antifungals for fungi; none effective for prions).
• 1 mark — Identifies prion resistance to standard sterilisation as a control difficulty and explains why (misfolded protein, not destroyed by heat/chemicals used on cells/viruses).
• 1 mark — Identifies absence of nucleic acid as a second control difficulty and explains why (no target for existing antiviral/antibiotic drugs).
• 1 mark — Evaluates secondary data method (slaughterhouse records): strength + limitation.
• 1 mark — Evaluates primary data method (post-mortem pathology): strength + limitation.
• 1 mark — Reaches an explicit, evidence-based judgement about the fit of BSE to the standard infectious disease model — affirming the fit while identifying where the model must be extended.

Q2 — Sample Band 6 response (7 marks), annotated

The claim is substantially incorrect, though it contains one narrow, defensible observation. [1 — overall evaluative judgement]

What is defensible: COVID-19 did demonstrate the rapid and large-scale impact that a highly transmissible infectious pathogen (SARS-CoV-2, a non-cellular virus) can have when it enters a fully susceptible global population without prior immunity. In that specific context — a novel pandemic — the immediate death toll and disruption exceeded that of many non-infectious diseases in the short term. [1 — identifies and concedes the one defensible element]

What is incorrect:

The claim conflates the definition of infectious disease (caused by a pathogen; transmissible) with the concept of severity and mortality. Transmissibility simply means a pathogen can pass from host to host; it says nothing about how lethal the disease is per infection, how long it lasts, or how many people it kills in total. Many infectious diseases (such as the common cold, caused by rhinovirus) are highly transmissible but rarely fatal. [1 — distinguishes definition from severity]

The claim is also factually wrong about global mortality. The lesson explicitly states that non-infectious diseases — including heart disease, type 2 diabetes, and cancer (melanoma) — are the leading causes of death globally. Coronary artery disease alone kills approximately 9 million people per year worldwide, far exceeding the annual death toll of the vast majority of infectious diseases in a non-pandemic year. Type 2 diabetes causes approximately 1.5 million deaths per year globally and is responsible for enormous disability-adjusted life years lost. These are not "manageable lifestyle problems" — they are the primary drivers of the global burden of disease. [1 — refutes "always more deadly" with lesson data; 1 — refutes "lifestyle problems" with named examples and mortality data]

The characterisation of non-infectious diseases as "not real diseases" is scientifically indefensible. The distinction between infectious and non-infectious disease is about cause and transmission, not medical legitimacy or severity. Type 2 diabetes and coronary artery disease involve pathophysiology (impaired insulin signalling; atherosclerotic plaque formation) as real and complex as any pathogen-driven process. [1 — refutes "not real diseases"]

Defensible reformulation: "Infectious and non-infectious diseases are defined by their cause — a pathogen versus genetic, lifestyle, or environmental factors — not by their severity. Both categories include conditions that can be fatal. Non-infectious diseases such as heart disease, type 2 diabetes, and cancer are the leading causes of global death, while infectious diseases such as COVID-19 can have catastrophic short-term impact particularly when novel pathogens encounter susceptible populations. Research priority and resource allocation should be informed by burden-of-disease data, not by a false hierarchy of seriousness." [1 — biologically defensible reformulation linking definitions to burden-of-disease framing]

Marking criteria:

• 1 mark — States an overall evaluative judgement (e.g. "the claim is substantially incorrect").
• 1 mark — Correctly identifies the one defensible element (COVID-19 showed large-scale rapid impact of a novel transmissible pathogen in a susceptible population).
• 1 mark — Distinguishes the definition of infectious disease (transmissibility + pathogen) from severity/mortality and explains why transmissibility alone does not imply greater danger.
• 1 mark — Refutes "always more deadly" using lesson data about non-infectious diseases being the leading global causes of death.
• 1 mark — Refutes "lifestyle problems, not real diseases" by referencing at least two named non-infectious diseases (heart disease, type 2 diabetes, melanoma) and their mortality/disease burden.
• 1 mark — Evaluates the claim that non-infectious diseases are not "real diseases" — must refer to the lesson's explicit distinction between cause/transmission and severity.
• 1 mark — Reformulates the claim into a biologically defensible statement that correctly frames both disease categories using the lesson's definitions and global health data.